Cite
Pembrolizumab-induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review
MLA
Theodoros P. Vassilakopoulos, et al. “Pembrolizumab-Induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review.” In Vivo (Athens, Greece), vol. 35, no. 6, July 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac64a12580082573c2dad1c37d964684&authtype=sso&custid=ns315887.
APA
Theodoros P. Vassilakopoulos, Aikaterini Bitsani, Wolfgang Bethge, Maria Dimou, & Panayiotis Panayiotidis. (2021). Pembrolizumab-induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review. In Vivo (Athens, Greece), 35(6).
Chicago
Theodoros P. Vassilakopoulos, Aikaterini Bitsani, Wolfgang Bethge, Maria Dimou, and Panayiotis Panayiotidis. 2021. “Pembrolizumab-Induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review.” In Vivo (Athens, Greece) 35 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac64a12580082573c2dad1c37d964684&authtype=sso&custid=ns315887.